Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

Rieke Alten; Hubert Nüßlein; Mauro Galeazzi; Hanns-Martin Lorenz; Michael T Nurmohamed; William G Bensen; Gerd R Burmester; Hans-Hartmut Peter; Karel Pavelka; Mélanie Chartier; Coralie Poncet; Christiane Rauch; Yedid Elbez; Manuela Le Bars

doi:10.1136/rmdopen-2015-000228

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Rheumatoid arthritis

Short report

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Alten R, Nüßlein H, Galeazzi M, et al

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

RMD Open 2016;2:e000228. doi: 10.1136/rmdopen-2015-000228

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password